PTEN and endometrial cancer: Overexpression of EMT-promoting FGFR2c [133] confers a worse prognosis in PTEN-defective endometrial carcinoma [196], whereas non-endometrioid endometrial cancers with wild-type PTEN lose E-cadherin expression en route to EMT [197].